Antiretroviral Therapy in AIDS

Broder, Samuel; Mitsuya, Hiroaki; Yarchoam, Robert; Pavlakis, George N.
October 1990
Annals of Internal Medicine;10/15/90, Vol. 113 Issue 8, p604
Academic Journal
Discusses the development of antiretroviral therapy for AIDS and related disorders. Summary of a Clinical Staff Conference on October 26, 1988 at the National Institutes of Health; Emergence of drug-resistant virus variants; Description of the activity of 2', 3'-dideoxynucleosides against other viruses; Discussion on cell infection by HIV through viral binding to the target cell receptor CD4 molecule; Types of drugs.


Related Articles

  • Reservoirs of Human Immunodeficiency Virus Type 1: The Main Obstacles to Viral Eradication. Pomerantz, Roger J. // Clinical Infectious Diseases;1/1/2002, Vol. 34 Issue 1, p91 

    Highly active antiretroviral therapy (HAART) has led to profound decreases in morbidity and mortality rates in human immunodeficiency virus type 1 (HIV-1)--infected persons, at least in the developed world. Many infected persons have plasma levels of HIV-1 RNA that are less than the limits of...

  • Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected Adults. Staszewski, Schlomo; Keiser, Philip; Montaner, Julio; Raffi, Francois; Gathe, Joe; Brotas, Vitor; Hicks, Charles; Hammer, Scott M.; Cooper, David; Johnson, Margaret; Tortell, Stephanie; Cutrell, Amy; Thorborn, Daren; Isaacs, Robin; Hetherington, Seth; Steel, Helen; Spreen, William // JAMA: Journal of the American Medical Association;3/7/2001, Vol. 285 Issue 9, p1155 

    Presents a study to evaluate antiretroviral equivalence and safety of an abacavir-lamivudine-zidovudine, a triple nucleoside combination regimen, compared with an indinavir-lamivudine-zidovudine regimen for the treatment of HIV infection. Design and setting; Patients; Interventions; Main...

  • Antiretroviral treatment to prevent mother-to-child transmission of HIV-1. McIntyre, J.; Gray, G. // South African Journal of Science;Jun2000, Vol. 96 Issue 6, p277 

    Deals with the antiretroviral treatment strategies to reduce mother-to-child transmission of HIV. Long and short-course zidovudine regimens; Long and short-course combination treatments; Ultra-short-course regimens.

  • VIRAL REBOUND DESPITE HAART AND IL-2.  // AIDS Patient Care & STDs;Feb2000, Vol. 14 Issue 2, p101 

    Presents research findings showing that two patients treated with highly active antiretoviral therapy (HAART) regimens and interleukin-2 (IL-2) and who had undetectable viral loads, had quick viral rebound soon after stopping therapy. Support of earlier reports that eradicating HIV from the...

  • Transmission Fitness of Drug-Resistant Human Immunodeficiency Virus and the Prevalence of Resistance in the Antiretroviral-Treated Population. Brown, Andrew J. Leigh; Frost, Simon D.W.; Mathews, W. Christopher; Dawson, Keith; Hellmann, Nicholas S.; Daar, Eric S.; Richman, Douglas D.; Little, Susan J. // Journal of Infectious Diseases;2/15/2003, Vol. 187 Issue 4, p683 

    Although the prevalence of drug-resistant strains in primary human immunodeficiency virus (HIV) infection in North America has recently increased, their transmission fitness remains unknown. The present study estimated the frequency of transmission of drug-resistant HIV from patients receiving...

  • Human Immunodeficiency Virus Infection with Human Granulocytic Ehrlichiosis Complicated by Symptomatic Lactic Acidosis. Springer, Sandra A.; Altice, Frederick L. // Clinical Infectious Diseases;6/15/2003, Vol. 36 Issue 12, pe162 

    Lactic acidosis has been reported as a complication associated with antiretroviral therapy; in particular, usually with use of nucleoside reverse-transcriptase inhibitors. We describe a human immunodeficiency virus(HIV)-infected patient with a history of lipodystrophy who presented with hepatic...

  • Progressive Multifocal Leukoencephalopathy in Patients with AIDS Receiving Highly Active... Tantisiriwat, Woraphot; Tebas, Pablo; Clifford, David B.; Powderly, William G.; Fichtenbaum, CArl J. // Clinical Infectious Diseases;5/1/1999, Vol. 28 Issue 5, p1152 

    Reports on cases of progressive multifocal leukoencephalopathy (PML) in HIV-positive patients receiving highly active antiretroviral therapy (HAART). Diagnosis; Clinical symptoms; Medical treatment.

  • Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy. Kulkosky, Joseph; Nunnari, Giuseppe; Otero, Miguel; Calarota, Sandra; Dornadula, Geetha; Hui Zhang; Malin, Anne; Sullivan, Julie; Yan Xu; DeSimone, Joseph; Babinchak, Timothy; Stern, John; Cavert, Winston; Haase, Ashley; Pomerantz, Roger J. // Journal of Infectious Diseases;11/15/2002, Vol. 186 Issue 10, p1403 

    Highly active antiretroviral therapy (HAART) has led to significant changes in mortality and morbidity in the human immunodeficiency virus type 1 (HIV-1) epidemic. Nevertheless, because of molecular mechanisms of viral persistence, HAART does not eradicate HIV-1. Didanosine and hydroxyurea were...

  • Combination therapies against HIV-1 infection: Exploring the concept of combining antiretroviral... Ferre, Francois; Moss, Ronald B. // AIDS Patient Care & STDs;Dec96, Vol. 10 Issue 6, p357 

    Explores the concept of combining antiretroviral drug treatments with HIV-1 immune-based therapies in asymptomatic individuals to combat HIV-1 infection. Effect of antiretroviral drug therapies in asymptomatic individuals; Goal of immune-based therapies; Result of two different treatment.

  • A Multi-sectorial Committee in Directing HIV/AIDS-Specific Interventions in the Occupational... Morris, Chester N.; Wilkinson, David; Stein, Zena; Cheevers, E.J. // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p153 

    Presents a descriptive analysis of a mechanism to coordinate and implement HIV prevention and care in the occupational setting. Composition of the multidisciplinary committee described; Initiation of the committee to coordinate a combined prevention-care initiative; Issues cited as important in...


Other Topics